Biotech

All Articles

Analysts examine Avidity's DMD succeed, uncovering distinctions in records

.Avidity Biosciences satisfied real estate investors with stage 1/2 records in Duchenne muscle dystr...

Actinogen's cortisol blocker stops working stage 2 depression research study

.Actinogen Medical's cortisol blocker has actually missed out on the major endpoint of a stage 2 res...

Bivictrix makes a decision going private only means to take ADC in to center

.Antibody-drug conjugates (ADCs) have actually gone to the center of several a billion-dollar biobuc...

TPG leadings up funds to $580M for assets all over lifestyle sciences

.Possession supervisor TPG, which has sustained biotechs such as Sionna Rehabs and Santa Clam Ana Bi...

Merck ceases period 3 TIGIT trial in lung cancer cells for futility

.Merck &amp Co.'s TIGIT system has endured an additional obstacle. Months after shuttering a period ...

After a difficult year, Exscientia folds right into Recursion

.After a year determined through pipeline cuts, the shift of its CEO and layoffs, Exscientia is goin...

Cullinan, after $25M deal, restore bispecific to Port

.Cullinan Therapy was impressed good enough with Harbour BioMed's bispecific immune system reactor t...

A deeper look at Fierce Biotech's Strong 15

.Within this week's incident of "The Top Pipe," our team are actually diving in to Strong Biotech's ...

Lilly encounters period 2 failing of tau-targeting med

.The confetti is still flying from Eli Lilly's party celebrating the commendation of Alzheimer's dis...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of notable leadership hirings, firings as we...